Amedisys, Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:Amedisys, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4068
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Amedisys, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Amedisys, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Amedisys Inc. (Amedisys or ‘the company’) is one of the leading hospice service and home health care service providers in the US. It operates and manages hospice inpatient units, Medicare-certified hospice and home health care centers and in various states of the US Puerto Rico and District of Columbia. In addition, it offers personalized health care services to various patients and their families and in-home healthcare and related services to the chronic, co-morbid and aging American population. The company is headquartered in Louisiana, the US.

Scope

- Detailed information on Amedisys, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amedisys, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amedisys, Inc. including a breakdown and examination of key business segments
- Intelligence on Amedisys, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amedisys, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Amedisys, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Amedisys, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Amedisys, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Amedisys, Inc.: Company Overview
Amedisys, Inc.: Overview and Key Facts
Amedisys, Inc.: Overview
Amedisys, Inc.: Key Facts
Amedisys, Inc.: Key Employees
Amedisys, Inc.: Key Employee Biographies
Amedisys, Inc.: Major Products and Services
Amedisys, Inc.: Company History
Amedisys, Inc.: Management Statement
Amedisys, Inc.: Locations and Subsidiaries
Amedisys, Inc.: Key Competitors
Amedisys, Inc.: Company Analysis
Amedisys, Inc.: Business Description
Amedisys, Inc.: SWOT Analysis
Amedisys, Inc.: SWOT Overview
Amedisys, Inc.: Strengths
Amedisys, Inc.: Weaknesses
Amedisys, Inc.: Opportunities
Amedisys, Inc.: Threats
Amedisys, Inc.: Corporate Financial Deals Activity
Amedisys, Inc.: Financial Deals Overview
Amedisys, Inc.: Targets and Partners
Amedisys, Inc.: Top Deals 2016 – 2020YTD*
Amedisys, Inc.: Advisors
Amedisys, Inc.: Top Legal Advisors
Amedisys, Inc.: Mergers and Acquisitions
Amedisys, Inc.: Recent Developments
Amedisys, Inc.: News and Events Summary
Amedisys, Inc.: Contracts
Amedisys, Inc.: Corporate Governance
Amedisys, Inc.: Financial Performance
Amedisys, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Amedisys, Inc.: Key Facts
Table 2: Amedisys, Inc.: Key Employees
Table 3: Amedisys, Inc.: Company History
Table 4: Amedisys, Inc.: Locations and Subsidiaries
Table 5: Amedisys, Inc.: Key Competitors
Table 6: Amedisys, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Amedisys, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Amedisys, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Amedisys, Inc.: Targets and Partners
Table 10: Amedisys, Inc.: Top Deals 2016 - 2020YTD*
Table 11: Amedisys, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Amedisys, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Amedisys, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Amedisys, Inc.: News and Events Summary
Table 15: Amedisys, Inc.: Contracts
Table 16: Amedisys, Inc.: Corporate Governance
Table 17: Amedisys, Inc.: Financial Performance
Table 18: Amedisys, Inc.: Strategy and Operations

★海外企業調査レポート[Amedisys, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pt Bank Central Asia Tbk:企業の戦略・SWOT・財務分析
    Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Selecta Biosciences Inc (SELB):製薬・医療:M&Aディール及び事業提携情報
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Baylor Scott & White Health-製薬・医療分野:企業M&A・提携分析
    Summary Baylor Scott & White Health (Baylor Scott & White) is a non-profit organization that provides medical care services. The organization provides medical education, medical services and conducts medical research. It offers medical services in the area of emergency care, cancer care, behavioral …
  • SS&C Technologies Holdings Inc.:企業のM&A・事業提携・投資動向
    SS&C Technologies Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SS&C Technologies Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Nutra Pharma Corp (NPHC):企業の財務・戦略的SWOT分析
    Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fiat Chrysler Automobiles NV:戦略・SWOT・企業財務分析
    Fiat Chrysler Automobiles NV - Strategy, SWOT and Corporate Finance Report Summary Fiat Chrysler Automobiles NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Reckitt Benckiser Group plc:企業の戦略・SWOT・財務情報
    Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report Summary Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ontario Power Generation Inc-エネルギー分野:企業M&A・提携分析
    Summary Ontario Power Generation Inc. (OPG) is an electricity generating company, fully owned by the Government of Ontario. It carries out the generation and sale of electricity in Ontario. The company generates electricity by utilizing various sources of energy including nuclear, hydroelectric, bio …
  • Hanwei Energy Services Corp (HE):企業の財務・戦略的SWOT分析
    Summary Hanwei Energy Services Corp (Hanwei Energy) is a chemical company that develops, manufactures and distributes plastic fibre reinforced piping systems. The company’s products include anhydride and amine cured frp pipes, fittings, fixtures and flanges. It offers client solutions such as pre-te …
  • Oncgnostics GmbH-医療機器分野:企業M&A・提携分析
    Summary Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the met …
  • Affymetrix, Inc.-医療機器分野:企業M&A・提携分析
    Summary Affymetrix, Inc. (Affymetrix) provides life science, and molecular diagnostic products for analysis of biological systems at gene, protein and cellular level. It offers products for two major applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument …
  • Aptiv Plc:企業の戦略・SWOT・財務分析
    Aptiv Plc - Strategy, SWOT and Corporate Finance Report Summary Aptiv Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Telefonica UK Limited:企業の戦略的SWOT分析
    Telefonica UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Microbot Medical Inc (MBOT):企業の財務・戦略的SWOT分析
    Summary Microbot Medical Inc (Microbot), formerly StemCells Inc, is a pre-clinical medical device company that researches, designs and develops micro-robotics assisted medical technologies for minimally invasive surgeries. The company’s product candidates include Self Cleaning Shunt, intended for th …
  • LG Electronics, Inc.:戦略・SWOT・企業財務分析
    LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kala Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company which focuses on nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase …
  • JD Sports Fashion Plc:企業の戦略・SWOT・財務情報
    JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report Summary JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hydra Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs. The company’s pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic areas including inflammation, pain, renal, anxiety and pulm …
  • Altria Group Inc (MO):企業の財務・戦略的SWOT分析
    Altria Group Inc (MO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CytomX Therapeutics Inc (CTMX):企業の財務・戦略的SWOT分析
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆